Table 4

Univariate analysis displaying correlations of the predefined determinants to EQ-5D dimensions and EQ VAS

EQ-5DEQ VAS
MOSCUAPDAD
NCorr.coefp ValueCorr.coefp ValueCorr.coefp ValueCorr.coefp ValueCorr.coefp ValueCorr.coefp Value
Age2130.090.190.050.490.070.320.060.390.060.38−0.060.31
Sex213−0.20*<0.05−0.030.70−0.23*<0.05−0.13*0.06−0.27*<0.050.23*<0.05
6MWT213−0.43*<0.05−0.28*<0.05−0.42*<0.05−0.30*<0.05−0.25*<0.050.51*<0.05
BMI2130.13*0.060.14*0.040.100.160.030.710.050.500.22*<0.05
BNP2030.19*0.010.010.890.15*0.030.13*0.070.19*0.01−0.100.14
Ongoing AC2130.090.19−0.050.450.020.730.020.80−0.010.85−0.060.38
Cardiopulmonary comorbidity2130.15*0.030.050.470.17*0.010.090.200.060.20−0.19*0.01
Active cancer2130.090.200.010.990.010.90−0.010.930.010.97−0.020.77
Reporting dyspnoea2130.16*0.020.13*0.050.29*<0.050.40*<0.050.110.11−0.37*<0.05
F-score1920.060.420.15*0.040.110.130.070.36−0.010.94−0.12*0.09
Recurrent VTE2130.010.93−0.060.35−0.020.730.060.35−0.010.95−0.020.77
Unemployed2130.100.130.080.270.22*<0.050.24*<0.050.27*<0.05−0.24*0.01
Disease duration213−0.020.77−0.020.79−0.030.64−0.040.58−0.070.320.13*0.05
  • *All values with α<0.10 retained for multiple regression analysis, explanatory variables recoded to 0=not having the condition and 1=having the condition, dimensions dichotomised in reporting problems=1 and not reporting problems=0.

  • 6MWT, 6 min walking test; AD, anxiety and depression; Age, age at inclusion, male sex=1; BMI, body mass index (kg/m2); BNP, brain natriuretic peptide; Corr. coef, Spearman's r correlation coefficient; EQ-5D, EuroQol five-dimension; EQ VAS, EuroQol visual analogue scale; F-score, Fredrikstad radiological score (higher scores associated with a more proximal location of the thrombus); MO, mobility; Ongoing AC, ongoing anticoagulant treatment; PD, pain and discomfort; SC, self-care; UA, usual activities; Unemployed, unemployed or unemployment because of long-term illness or disability retirement and disease duration=time in years from PE diagnosis to study inclusion.